CGON
CG Oncology, Inc.
72.61
-0.03 (-0.04%)
52w low 37.01
80.97 high
81.0% of range
Financial Analysis
| (USD) | Dec 21 | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|---|---|
| Total Revenue | -- | 191.00K | 204.00K | 1.14M | 4.04M | |
| Cost of Revenue | -- | -- | 0.00 | 0.00 | 4.65M | |
| Gross Profit | -- | -- | 204.00K | 1.14M | -607.00K | |
| Operating Expenses | -- | 35.44M | 55.65M | 115.81M | 190.17M | |
| R&D | -- | 29.03M | 45.75M | 82.10M | 116.64M | |
| SG&A | -- | 6.41M | 9.90M | 33.70M | 73.53M | |
| Operating Income | -- | -35.25M | -55.45M | -114.67M | -190.77M | |
| EBITDA | -- | -35.23M | -55.43M | -114.63M | -189.33M | |
| Pretax Income | -- | -35.44M | -48.61M | -88.04M | -161.00M | |
| Net Income | -- | -35.44M | -48.61M | -88.04M | -161.00M | |
| EPS Diluted | -- | -11.71 | -15.65 | -1.41 | -2.08 | |
| Diluted Shares | -- | 3.74M | 4.33M | 62.50M | 77.30M |
Revenue CAGR
+176.6%
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
+254.7%